S&P 500 Futures
(-0.09%) 5 303.50 points
Dow J Futures
(0.01%) 40 149 points
Nasdaq Futures
(-0.15%) 18 476 points
Oil
(1.63%) $82.68
Gas
(1.40%) $1.742
Gold
(0.73%) $2 228.80
Silver
(0.24%) $24.81
Platinum
(0.77%) $916.70
USD/EUR
(0.26%) $0.926
USD/NOK
(0.51%) $10.82
USD/GBP
(0.01%) $0.791
USD/RUB
(-0.14%) $92.31

Realtime updates for Kronos Bio, Inc. [KRON]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated27 Mar 2024 @ 16:00

4.20% $ 1.240

Live Chart Being Loaded With Signals

Commentary (27 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Kronos Bio, Inc.

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity...

Stats
Today's Volume 115 316
Average Volume 255 324
Market Cap 74.52M
EPS $0 ( 2024-03-20 )
Next earnings date ( $-0.450 ) 2024-05-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.640
ATR14 $0.00800 (0.64%)
Insider Trading
Date Person Action Amount type
2024-02-21 Olek Elizabeth A Sell 7 368 Common Stock
2024-02-16 Olek Elizabeth A Sell 0 Common Stock
2024-02-16 Olek Elizabeth A Sell 89 120 Stock Option (Right to Buy)
2024-02-16 Olek Elizabeth A Sell 145 795 Stock Option (Right to Buy)
2024-02-16 Olek Elizabeth A Sell 87 500 Stock Option (Right to Buy)
INSIDER POWER
46.62
Last 97 transactions
Buy: 7 377 688 | Sell: 1 665 671

Volume Correlation

Long: 0.01 (neutral)
Short: -0.77 (moderate negative)
Signal:(45.698) Neutral

Kronos Bio, Inc. Correlation

10 Most Positive Correlations
VVOS0.892
PASG0.886
SRTS0.876
SGBX0.876
FREQ0.863
ATHE0.858
CNDT0.852
FOSL0.846
KOD0.841
VNET0.84
10 Most Negative Correlations
TYHT-0.846
VERX-0.827
BLCT-0.81
HSTM-0.81
XOG-0.806

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kronos Bio, Inc. Correlation - Currency/Commodity

The country flag -0.38
( neutral )
The country flag 0.03
( neutral )
The country flag 0.00
( neutral )
The country flag 0.54
( weak )
The country flag 0.00
( neutral )
The country flag 0.28
( neutral )

Kronos Bio, Inc. Financials

Annual 2023
Revenue: $6.29M
Gross Profit: $1.37M (21.82 %)
EPS: $-1.950
Q4 2023
Revenue: $2.29M
Gross Profit: $1.81M (79.09 %)
EPS: $-0.430
Q3 2023
Revenue: $917 000
Gross Profit: $407 000 (44.38 %)
EPS: $-0.540
Q2 2023
Revenue: $1.86M
Gross Profit: $685 000 (36.75 %)
EPS: $-0.520

Financial Reports:

No articles found.

Kronos Bio, Inc.

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The company planned registrational phase 3 clinical trial of ENTO in combination with induction chemotherapy in acute myeloid leukemia patients with NPM1 mutations. It is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in San Mateo, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators